Ballicules.com
REMS restricted

Macitentan

OPSUMIT

Pronunciation: ma-si-TEN-tan (OP-sum-it)

Macitentan ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Macitentan ballicule

What it isEndothelin receptor antagonist; pulmonary arterial hypertension.

Why this oneCompared with bosentan, it penetrates tissue better and does not require routine monthly liver testing.

What limits itEmbryo-fetal toxicity requires restricted dispensing and pregnancy prevention. Anemia and peripheral edema can limit use.

Macitentan molecular structure (skeletal formula)
Molecular structure: Macitentan

FDA-approved for

Classes and tags

Clinical profile

Therapeutic safety burden3 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk4 / 4

Legacy pregnancy categoryUnknown / historical label unavailable

Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.

FDA label

BOXED WARNING Embryo-fetal toxicity — contraindicated in pregnancy; exclude pregnancy before starting and use effective contraception during and for 1 month after treatment.
FDA dosingPopulationStartTargetMax
Pulmonary arterial hypertension (PAH)Adults10 mg QD10 mg QD10 mg QD

Renal Undefined

Hepatic Undefined

Instructions

Available strengths

Contraindications

Cautions

Adverse reactions

Pregnancy Contraindicated; teratogenic in animals at all doses; may cause fetal harm.

Lactation Advise not to breastfeed; no human data.

Cost

Macitentan (OPSUMIT)
Strength#/mogeneric $/moCostPlus
10 mgtab30 qdoffered
NADAC is a voluntary CMS survey of what retail community pharmacies pay for the drugs they stock. Macitentan is dispensed outside retail pharmacies, so it rarely appears on surveyed invoices.

Generic entry2021

Open Macitentan in the interactive console ↗

Self-check